Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Viavi Solutions Inc. (NASDAQ: VIAV) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures alongside AI‑generated summaries. As a global provider of network test, monitoring and assurance solutions and optical security and light management technologies, VIAVI uses its SEC reports to describe its segment performance, capital structure, governance and material events.
Investors can review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for detailed information on the Network and Service Enablement and Optical Security and Performance Products segments, geographic revenue breakdowns, risk factors and management’s discussion and analysis. Current reports on Form 8‑K document significant developments such as the completion of the acquisition of Spirent Communications plc’s high-speed ethernet, network security and channel emulation testing business, entry into term loan and revolving credit agreements, issuance and exchange of Senior Convertible Notes, and share exchange transactions.
This page also surfaces filings related to corporate governance and shareholder matters, including the definitive proxy statement (DEF 14A) for the annual meeting of stockholders and amendments to the certificate of incorporation. Where applicable, Form 3, 4 and 5 insider transaction reports can be used to track trading activity by directors and officers.
Stock Titan’s AI features help interpret lengthy documents by highlighting key terms such as segment revenue trends, leverage and debt instruments, equity incentive plans, and amendments to governance documents. Real‑time updates from EDGAR ensure that new VIAV filings, from earnings‑related 8‑Ks to financing agreements, appear promptly with concise explanations of their significance.
Viavi Solutions Inc. (VIAV) director Eugenia Corrales received an award of 6,768 restricted stock units (RSUs) on 08/28/2025. The RSUs were granted at a $0 exercise/conversion price and are reported as directly owned following the transaction, with 6,768 shares underlying the award. The units vest on the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders, and the filing states there is no expiration date on the RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/29/2025.
Form 144 filed for Viavi Solutions Inc. (VIAV) shows a proposed sale of 13,115 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $146,560.13. The filing lists the number of outstanding shares as 223,245,915 and identifies the approximate date of sale as 08/29/2025 on NASDAQ. The securities were acquired on 08/28/2025 as restricted stock from the issuer, with payment dated 08/28/2025. The filer reports no securities sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes reliance possibilities for a Rule 10b5-1 trading plan if applicable. The issuer name and some filer contact details are not provided in the visible content.
Viavi Solutions Inc. (VIAV) submitted a Form 144 notice for a planned sale of 11,873 common shares valued at $132,693.84, to be executed approximately on 08/29/2025 on the NASDAQ. The shares represent a small portion of the company's common stock, with 223,245,915 shares outstanding, and were acquired as restricted stock from the issuer on 08/28/2025. The filing reports no sales by the seller in the past three months and indicates the transaction will be brokered by Morgan Stanley Smith Barney LLC. The filer attests they are not aware of undisclosed material adverse information and notes the usual Rule 10b5-1/attestation language on trading plans and criminal penalties for misstatements.
Viavi Solutions Inc. filed an 8-K reporting a material event and furnished two exhibits: an indenture dated August 20, 2025 between the company and U.S. Bank Trust Company, National Association as trustee, and the form of 0.625% Senior Convertible Notes due 2031 (included as part of the indenture). The filing lists the company’s principal contact information and is signed by Ilan Daskal, Chief Financial Officer, as the duly authorized officer. The exhibits indicate the company has documented the legal framework and the note terms for a convertible debt instrument carrying a stated interest rate of 0.625% and a 2031 maturity.
Viavi Solutions Inc. entered into privately negotiated exchange and subscription agreements to issue $250 million aggregate principal amount of new 0.625% Senior Convertible Notes due 2031. The deal includes about $100.9 million of new notes issued in exchange for approximately $97.5 million of its 1.625% Senior Convertible Notes due 2026 and about $149.1 million of new notes sold for cash to institutional investors under Securities Act exemptions. The company will cancel the exchanged 2026 notes and receive gross cash proceeds of about $149.1 million before fees. The new notes are convertible into cash and, if applicable, common stock at an initial rate of 72.5295 shares per $1,000 principal (a conversion price of roughly $13.79 per share, a 25% premium to the $11.03 closing price on August 13, 2025), with a current maximum of 22,665,450 shares issuable upon conversion.
Viavi Solutions Inc. agreed to issue $250 million aggregate principal amount of 0.625% Senior Convertible Notes due 2031, consisting of approximately $100.9 million of New Notes exchanged for about $97.5 million principal amount of its existing 1.625% Senior Convertible Notes due 2026 and approximately $149.1 million of New Notes sold for cash. After the Exchange Transactions, approximately $152.5 million principal amount of the 2026 Notes will remain outstanding.
The company expects to use net proceeds from the Subscription Transactions to repay a portion of the 2026 Notes upon maturity and expects the Transactions to close on or about August 20, 2025. In connection with the issuance of the New Notes, the company expects to repurchase approximately $30 million of common stock at $11.03 per share and the placement agent intends to purchase about $25 million of shares at a 5% discount to that price. Forms of the agreements and a press release are filed as exhibits.
Viavi Solutions Inc. filed an automatic shelf registration (Form S-3) dated August 11, 2025 that permits the company and selling security holders to offer from time to time a variety of securities including common stock, preferred stock, depositary shares, debt securities, warrants, purchase contracts, rights, and units. The prospectus states offerings will be made in one or more series and that specific terms will be provided in prospectus supplements. The company noted its common stock trades on Nasdaq under VIAV and closed at $10.93 per share on August 8, 2025.
Corporate details in the prospectus include headquarters in Chandler, Arizona, and authorized capital of 1,001,000,000 shares (1,000,000,000 common; 1,000,000 preferred). The board may designate and issue preferred stock without further stockholder action. Use of proceeds is described as for general corporate purposes with no specific planned uses; management will have broad discretion. The filing incorporates risk factors and discloses anti-takeover and indemnification provisions in the certificate of incorporation and bylaws.
Viavi Solutions Inc. provides network test, monitoring and assurance solutions and optical security and performance products across two reportable segments: Network and Service Enablement (NSE) and Optical Security and Performance Products (OSP), with segment reporting realigned effective March 30, 2025. NSE serves telecom, cloud, enterprise and defense markets; OSP supplies anti-counterfeiting pigments and 3D sensing optics used on banknotes in more than 100 countries.
Key facts disclosed include an aggregate market value of approximately $2.2 billion (Dec 28, 2024), 223,245,915 shares outstanding (July 26, 2025), ~3,600 employees, ~1,085 U.S. patents and 2,075 foreign patents with 1,164 pending, a TRIR of 0.08, a fiscal-2024 grant of $21.7 million over three years, manufacturing in China, France, Germany, the U.K. and the U.S., and contract manufacturers in China and Thailand. The company completed the Inertial Labs acquisition in January 2025 and disclosed a proposed acquisition of Spirent business lines (estimated close by end of Sept 2025, subject to customary conditions). Material risks highlighted include customer concentration (including a strategic alliance with SICPA), geopolitical and trade disruptions, supply-chain concentration, rapid technological change, cybersecurity threats, restructuring actions and increased leverage from issued notes (including convertible and senior notes).
FAQ
What is the current stock price of Viavi Solutions (VIAV)?
What is the market cap of Viavi Solutions (VIAV)?
